Novotech Wins CRO Contract for Covid-19 Clinical Trial in South Korea

Clinical Research |  News | 0 Comment | 09 Mar, 2020

Asia-Pacific’s largest specialist biotech CRO Novotech has been selected for the Komipharm International clin...Read more

WuXi Biologics congratulates Immutep on positive interim data for IMP-321

Clinical Research |  News | 0 Comment | 24 Feb, 2020

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...Read more

AVROBIO announces clinical and regulatory progress for Gaucher Disease Program

Clinical Research |  News | 0 Comment | 17 Jan, 2020

US based AVROBIO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic...Read more

PPD expands clinical capabilities in China

Clinical Research |  News | 0 Comment | 15 Jan, 2020

PPD, Inc. ( PPD ) has expanded its China operations and leadership team to provide more international and Chin...Read more

Genome & Company inks clinical trial collaboration

Clinical Research |  News | 0 Comment | 15 Jan, 2020

Genome & Company, a clinical-stage biotechnology company based in Seongnam, Republic of Korea, has announced th...Read more

Hummingbird Publishes Preclinical efficacy of HMBD-001 in HER3 driven Cancers

Clinical Research |  News | 0 Comment | 08 Jan, 2020

Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrou...Read more

CStone initiates CS1001 trial to treat ESCC in China

Clinical Research |  News | 0 Comment | 08 Jan, 2020

CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Co...Read more

Transgene, NEC initiate trials with AI-Powered Cancer Vaccine

Clinical Research |  News | 0 Comment | 07 Jan, 2020

French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of canc...Read more

Eisai presented research data on Eribulin (Halaven) at 42nd Annual SABCS2019

Clinical Research |  News | 0 Comment | 16 Dec, 2019

Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halich...Read more

Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference

Clinical Research |  News | 0 Comment | 31 Dec, 2019

Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading...Read more

Roche’s Ph III cancer immunotherapy trial reveals positive results for liver cancer

Clinical Research |  News | 0 Comment | 18 Dec, 2019

Liver cancer is the fourth most common cancer among men and affects approximately 24 individuals in every 100,000 people...Read more

NeuClone announces Positive Ph I results of Herceptin® (Trastuzumab) Biosimilar

Clinical Research |  News | 0 Comment | 13 Dec, 2019

NeuClone Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality ...Read more

Takeda presents Phase III Trial results in patients with amyloidosis

Clinical Research |  News | 0 Comment | 09 Dec, 2019

Japan based Takeda Pharmaceutical Company Limited announced the presentation of the results of tourmaline-AL1 trial in a...Read more

CASI Pharma gets China approval Of CNCT19 Clinical Trial Applications

Clinical Research |  News | 0 Comment | 04 Dec, 2019

CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therap...Read more

Seattle Genetics, Astellas announce Clinical Trial collaboration with Merck

Clinical Research |  News | 0 Comment | 03 Dec, 2019

Seattle Genetics, Inc. and Astellas Pharma Inc.have announced a clinical collaboration agreement with Merck, k...Read more

Combination of Immunotherapy and VEGF Inhibitor Improves Survival in HCC

Clinical Research |  News | 0 Comment | 22 Nov, 2019

Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves over...Read more

Trastuzumab Biosimilar HLX02 Met Primary Endpoint in Breast Cancer

Clinical Research |  News | 0 Comment | 22 Nov, 2019

The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epi...Read more

CStone announces first patient dosed in the Phase I study of ivosidenib

Clinical Research |  News | 0 Comment | 20 Nov, 2019

CStone Pharmaceuticals on 20 Nov 2019 announced that the first patient has been dosed in Phase I bridging the registrati...Read more